» Articles » PMID: 9353321

Tissue Factor is Induced by Monocyte Chemoattractant Protein-1 in Human Aortic Smooth Muscle and THP-1 Cells

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1997 Nov 14
PMID 9353321
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

Monocyte chemoattractant protein-1 (MCP-1) is a C-C chemokine thought to play a major role in recruiting monocytes to the atherosclerotic plaque. Tissue factor (TF), the initiator of coagulation, is found in the atherosclerotic plaque, macrophages, and human aortic smooth muscle cells (SMC). The exposure of TF during plaque rupture likely induces acute thrombosis, leading to myocardial infarction and stroke. This report demonstrates that MCP-1 induces the accumulation of TF mRNA and protein in SMC and in THP-1 myelomonocytic leukemia cells. MCP-1 also induces TF activity on the surface of human SMC. The induction of TF by MCP-1 in SMC is inhibited by pertussis toxin, suggesting that the SMC MCP-1 receptor is coupled to a Gi-protein. Chelation of intracellular calcium and inhibition of protein kinase C block the induction of TF by MCP-1, suggesting that in SMC it is mediated by activation of phospholipase C. SMC bind MCP-1 with a Kd similar to that previously reported for macrophages. However, mRNA encoding the macrophage MCP-1 receptors, CCR2A and B, is not present in SMC, indicating that they possess a distinct MCP-1 receptor. These data suggest that in addition to being a chemoattractant, MCP-1 may have a procoagulant function and raise the possibility of an autocrine pathway in which MCP-1, secreted by SMC and macrophages, induces TF activity in these same cells.

Citing Articles

Challenging the notion of endothelial infection by SARS-CoV-2: insights from the current scientific evidence.

Subramaniam S, Jose A, Kenney D, OConnell A, Bosmann M, Douam F Front Immunol. 2025; 16:1443932.

PMID: 39967675 PMC: 11832389. DOI: 10.3389/fimmu.2025.1443932.


Laboratory and clinical haemostatic aberrations in primary dermatologic disease: A review.

Sharma D, Thomas S, Moody T, Taylor M, Ituarte B, Georgeson C Thromb J. 2024; 22(1):101.

PMID: 39533305 PMC: 11558853. DOI: 10.1186/s12959-024-00665-w.


Immunity and Coagulation in COVID-19.

Avdonin P, Blinova M, Serkova A, Komleva L, Avdonin P Int J Mol Sci. 2024; 25(20).

PMID: 39457048 PMC: 11508857. DOI: 10.3390/ijms252011267.


Alleviating iatrogenic effects of paclitaxel via antiinflammatory treatment.

Zhang M, Lotfollahzadeh S, Elzinad N, Yang X, Elsadawi M, Gower A Vasc Med. 2024; 29(4):369-380.

PMID: 38623630 PMC: 11365010. DOI: 10.1177/1358863X241231942.


Sustained and intermittent hypoxia differentially modulate primary monocyte immunothrombotic responses to IL-1β stimulation.

Wahlund C, Caglayan S, Czarnewski P, Hansen J, Snir O Front Immunol. 2023; 14:1240597.

PMID: 37753073 PMC: 10518394. DOI: 10.3389/fimmu.2023.1240597.